| Name | [(3R)-3-hydroxybutyl] (3R)-3-hydroxybutanoate | 
|---|---|
| Synonyms | 
                                
                                3-hydroxybutyl-(R)-3-hydroxybutyrate
                                
                                
                                 (3R)-hydroxybutyl (3R)-hydroxybutyrate Ketone Ester BD-AcAc 2 Ketone Ester  | 
                        
| Description | BD-AcAc 2, added in diet, could elevated mean blood ketone bodies of 3.5 mm and lowered plasma glucose, insulin, and leptin in animals; ketone ester given orally would delay CNS-OT seizures in rats breathing hyperbaric oxygen.IC50 value:Target:a ketone ester given orally as R,S-1,3-butanediol acetoacetate diester (BD-AcAc(2)) would delay CNS-OT seizures in rats breathing hyperbaric oxygen (HBO(2)). Adult male rats (n = 60) were implanted with radiotelemetry units to measure electroencephalogram (EEG). One week postsurgery, rats were administered a single oral dose of BD-AcAc(2), 1,3-butanediol (BD), or water 30 min before being placed into a hyperbaric chamber and pressurized to 5 atmospheres absolute (ATA) O2 [1]. Beginning at a presymptomatic age, 2 groups of male 3xTgAD mice were fed a diet containing a physiological enantiomeric precursor of ketone bodies (KET) or an isocaloric carbohydrate diet. The results of behavioral tests performed at 4 and 7 months after diet initiation revealed that KET-fed mice exhibited significantly less anxiety in 2 different tests. 3xTgAD mice on the KET diet also exhibited significant, albeit relatively subtle, improvements in performance on learning and memory tests. Immunohistochemical analyses revealed that KET-fed mice exhibited decreased Aβ deposition in the subiculum, CA1 and CA3 regions of the hippocampus, and the amygdala [2]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.102 | 
|---|---|
| Boiling Point | 269 ºC | 
| Molecular Formula | C8H16O4 | 
| Molecular Weight | 176.21000 | 
| Flash Point | 101 ºC | 
| Exact Mass | 176.10500 | 
| PSA | 66.76000 | 
| LogP | 0.07140 | 
| 
                                
                                
                                
                                
                                 ~%  
                                    1208313-97-6  | 
                        
| Literature: Isis Innovation Limited; Government of the USA, as Represented by the Secretary , Department of Health And; Human Services Patent: US2011/237666 A1, 2011 ; Location in patent: Page/Page column 5 ; | 
| Precursor 2 | |
|---|---|
| DownStream 0 | |